Shilpa Medicare Ltd

Shilpa Medicare Annual General Meeting

Shilpa Medicare has initiated a postal ballot for shifting its registered office between states. Shareholders will vote on altering the Memorandum of Association via special resolution.

Shilpa Medicare Earnings Call: Key Takeaways

Shilpa Medicare delivered record FY26 performance with 18% revenue growth and 30% EBITDA growth. Strategy focuses on high-value CDMO partnerships, specialized formulations like NorUDCA, and a robust biosimilar pipeline.

Shilpa Medicare Capacity Expansion

Shilpa Medicare is seeking shareholder approval to shift its registered office from Karnataka to Mumbai, Maharashtra. The move aims to improve access to financial institutions and investors.

Shilpa Medicare Management Change

Shilpa Medicare appointed Aneja Associates as Internal Auditor for a twelve-month term. The firm brings forty years of governance and risk experience to the company.

Execution

12 months

Shilpa Medicare Dividend

Shilpa Medicare recommended a final dividend of ₹0.6 per equity share for 2026. This distribution reward remains subject to upcoming shareholder approval.

Shilpa Medicare Q4 FY26 Results: Net Profit ₹107.8 Cr, Up 643.4% YoY

Shilpa Medicare Ltd reported revenue from operations of ₹437 Cr (+32.1% YoY) and net profit of ₹107.8 Cr (+643.4% YoY) for Q4 FY26.

Key figure

Net profit ₹107.8 Cr · +643.4% YoY

Shilpa Medicare Financial Results

Shilpa Medicare reported audited FY26 results and recommended a Re. 0.60 final dividend. The board also approved a 28% strategic investment in Neo Green Power.

Value

₹0.60 Cr

Shilpa Medicare Earnings Call: Key Takeaways

Shilpa Medicare reported record quarterly revenue and EBITDA, signaling a shift from heavy R&D investment to commercial execution across API, formulations, and biologics.

Shilpa Medicare Board Meeting Date

Shilpa Medicare scheduled a board meeting for 22 May 2026 to approve FY26 financial results. Directors will also consider a dividend recommendation for the financial year.

Shilpa Medicare Management Change

Shilpa Medicare Limited has appointed Dr. Vellaian Karuppiah as Chief Operating Officer (COO) effective April 23, 2026. Dr. Karuppiah brings over 33 years of pharmaceutical experience from firms like Gland Pharma and Dr. Reddy’s. He is expected to strengthen formulation business operations and enhance operational efficiencies.

Shilpa Medicare Management Change

Shilpa Medicare Limited has appointed Dr. Vellaian Karuppiah as Chief Operating Officer (COO) – Formulations, effective 23 April 2026. Dr. Karuppiah brings over 33 years of pharmaceutical experience from firms like Gland Pharma and Dr. Reddy’s. He is expected to strengthen the company’s formulation business and operational efficiencies.

Shilpa Medicare Management Change

Mr. Jayant Karajgi, the Chief Operating Officer (COO) - Formulations of Shilpa Medicare Limited, retired from his position effective April 22, 2026. He was categorized as Senior Management Personnel.

Shilpa Medicare Management Change

Dr. Jayant Karajgi, Chief Operating Officer (COO) – Formulations of Shilpa Medicare Limited, retired from the company effective April 22, 2026. He also ceased to be a Senior Management Personnel (SMP) on the same date. This leadership transition follows regulatory disclosure requirements under SEBI (LODR) Regulations, 2015.

Shilpa Medicare Debt & Borrowing

Shilpa Medicare Limited informed stock exchanges that it does not qualify as a Large Corporate for the financial year ended March 31, 2025. The company reported zero outstanding long-term borrowings under the SEBI debt framework. India Ratings and Research assigned the company an A+ credit rating with a positive outlook.

Shilpa Medicare Other Announcement

Shilpa Medicare Limited submitted its quarterly compliance certificate under Regulation 74(5) of SEBI Regulations for the period ended March 31, 2026. Issued by KFin Technologies Limited, the certificate confirms that security details for dematerialized and rematerialized shares have been furnished to the relevant stock exchanges.

Shilpa Medicare Share Pledge

Shilpa Medicare Limited's promoter group, led by Mr. Omprakash Innani, disclosed a 40.13% aggregate holding as of March 31, 2026. The filing confirms various share pledges made by promoter group members, including Mr. Vishnukant Bhutada and Mr. Ramakant Innani, during the financial year. Total promoter group holding stands at 7,84,96,648 shares.